Skip to main content
. 2018 Jul 25;10(2):392–398. doi: 10.1111/jdi.12877

Table 3.

Relationship between anti‐BP180 antibody and dipeptidyl peptidase‐4 inhibitor treatment

DPP4I group (n = 32) Non‐DPP4I group (n = 136) P‐value
Anti‐BP180 antibody‐positive (%) 21 (65.6) 112 (82.3) 0.0360
Anti BP180 antibody titer (SD) 206.7 (238.5) 551.1 (1,323.6) 0.0136

DPP4I, dipeptidyl peptidase‐4 inhibitor; SD, standard deviation.